Recent News

Case Study: Chemoimmunotherapy Combination in Merkel Cell Carcinoma

Autoimmune Dermatosis in a Pembrolizumab-Treated Patient With Merkel Cell Carcinoma: Case Study

COVID-19, Merkel Cell Carcinoma, and Immunotherapy: Case Study

Hydrochlorothiazide and Non-Melanoma Skin Cancer in Asian Patients

ESMO 2020: Cemiplimab in Cutaneous Squamous Cell Carcinoma: Changes in Pain and Tumor Response

Bone Marrow Involvement From Merkel Cell Carcinoma: Case Study

ESMO 2020: Targeting PD-1 in Merkel Cell Carcinoma

Epidermal Radioisotope Therapy Using Rhenium-188 for Non-Melanoma Skin Cancer

Do Topical Calcineurin Inhibitors Increase the Risk for Skin Cancer?

Finnish Study Shows Benefit of Full-Body Skin Exams in Older Adults

Effects of Immunosuppression in Merkel Cell Carcinoma

Hydrochlorothiazide Drug Label Change to Include Small Risk of Skin Cancer

Invasive Melanoma Arising From Basal Cell Carcinoma Passenger Melanocytes: Case Study

Does Facility Volume Impact Survival Outcomes in Merkel Cell Carcinoma?

Is Hydrochlorothiazide Linked to Increased Risk for Skin Cancer?

Perineural Invasion in Basal Cell Carcinoma

KEYNOTE-629: Pembrolizumab in Metastatic Cutaneous Squamous Cell Carcinoma

Front-Line Immunotherapy for Locally Advanced Basal Cell Carcinoma: Case Studies

Sex-Dependent Distribution of Non-Melanoma Skin Cancers of the Pinna

Sun Health Behaviors and Skin Cancer Risk in Children: Public Health Report From Ireland

Case Study Features Association Between Rare Skin Condition and Basal Cell Carcinoma

Identifying High-Risk Patients With Cutaneous Squamous Cell Carcinoma for Clinical Trial

Health-Related Quality of Life With Cemiplimab for Skin Cancer

Call to Action: Skin Cancer Surveillance in Patients With Organ Transplants

AACR II: Linking HPV Infection to Skin Cancer in Patients With CLL

Immune-Mediated Adverse Events With Concomitant Radiotherapy and Immunotherapy

AACR II: Does Cyclooxygenase-2 Inhibitor Use Reduce the Risk of Skin Cancer?

AACR II: Early Tanning Bed Use and Risk for Skin Cancer

Pembrolizumab Approved by FDA for Cutaneous Squamous Cell Carcinoma

AACR II: Do Permanent Hair Dyes Increase the Risk of Skin Cancer?

ASCO20: Upfront Treatment With Cemiplimab for Locally Advanced Skin Cancer

Preclinical Study of Plant Flavonoid in Treatment of Squamous Cell Skin Cancer

ASCO20: Longer-Term Follow-Up Supports Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma

ASCO20: Predicting Subclinical Progression of Squamous Cell Carcinoma

ASCO20: Total-Body Skin Exams and Diagnosis of Skin Cancers

ASCO20: Targeting MDM2 in Merkel Cell Carcinoma

ASCO20: Preserving Eye Function in Locally Advanced Orbital/Periocular Basal Cell Carcinoma

Skin Cancer Awareness Month: Recommendations for Prevention

Managing Patients With Skin Cancer During the COVID-19 Pandemic

Exploring Staph Bacteria’s Connection to Growth of Skin Cancers

DDW 2020: Risk of Skin Cancer in Patients With Inflammatory Bowel Disease

COVID-19 and Skin Cancer: Meeting Clinical Challenges in Dermatology

Non-Melanoma Skin Cancer: A Continual Problem for Outdoor Workers

STAT3 Pathway: Therapeutic Target in Cutaneous Squamous Cell Carcinoma?

Pembrolizumab Receives FDA Accelerated Approval for Alternative Dosing Schedule